Together these data paint a picture of MSLN as a less lineage specific marker that is upregulated in cancer to promote proliferation and migration of tumor cells [51], while LRRN4 and UPK3B are more specific lineage markers that provide no competitive advantage to the tumor so can be lost during tumor progression. This evidence concerns the gene MSLN and cancer.